Study Details

Back
Study ID 5094-CL-0201
Study Title Phase 2a Study of ASP5094 - A Phase 2a, Randomized, Placebo-controlled, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate -
Clinicaltrials.gov Identifier NCT03257852
Compound Name ASP5094
Medical Indication or Disease Rheumatoid arthritis
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 29-Sep-2017
Study Completion Date 16-Oct-2018
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS